Related Experiment Videos
Apoptosis and cancer chemotherapy
1CRC Molecular and Cellular Pharmacology Group, School of Biological Sciences, G38 Stopford Building, Oxford Road, Manchester, UK M13 9PT. guy.makin@man.ac.uk
Trends in Cell Biology
|October 31, 2001
Summary
Understanding drug-induced apoptosis is key to overcoming cancer drug resistance. A new framework highlights how balancing survival and death signals, particularly involving Bcl-2 family proteins, offers therapeutic targets for cancer treatment.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Cell Death Mechanisms
Background:
- Growing interest in apoptosis (programmed cell death) among cancer biologists.
- Hope that understanding cell death mechanisms will elucidate tumor drug resistance.
- Need for a framework to understand drug-induced apoptosis in cancer.
Purpose of the Study:
- To describe a framework for drug-induced apoptosis in cancer.
- To identify how intrinsic and extrinsic survival signals interact with drug-induced death signals.
- To explore therapeutic intervention points for overcoming drug resistance.
Main Methods:
- Analysis of the balance between pro- and anti-apoptotic signals.
- Investigation of the role of Bcl-2 family proteins in controlling cellular fate.
- Framework development based on mechanistic understanding of apoptosis.
Main Results:
- A framework for drug-induced apoptosis has been described.
- Pro- and anti-apoptotic signals converge on Bcl-2 family proteins.
- This balance dictates the ultimate cellular fate.
Conclusions:
- The described framework identifies multiple points for therapeutic intervention against drug resistance.
- Novel molecular targets for inducing apoptosis in cancer cells have been generated.
- Mechanistic insights into apoptosis can inform cancer drug resistance strategies.